SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis-Reference-Cited by-同舟云学术

SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis

Published:2024-03 Issue:3 Volume:5 Page:e235-e246
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Raglow Zoe^ORCID,Surie Diya,Chappell James D,Zhu Yuwei,Martin Emily T,Kwon Jennie H,Frosch Anne E,Mohamed Amira,Gilbert Julie,Bendall Emily E,Bahr Auden^ORCID,Halasa Natasha,Talbot H Keipp,Grijalva Carlos G,Baughman Adrienne,Womack Kelsey N,Johnson Cassandra^ORCID,Swan Sydney A,Koumans Emilia,McMorrow Meredith L,Harcourt Jennifer L,Atherton Lydia J,Burroughs Ashley^ORCID,Thornburg Natalie J,Self Wesley H,Lauring Adam S^ORCID

Publisher

Elsevier BV

Reference30 articles.

1. The biological and clinical significance of emerging SARS-CoV-2 variants;Tao;Nat Rev Genet,2021

2. Association between mRNA vaccination and COVID-19 hospitalization and disease severity;Tenforde;JAMA,2021

3. Remdesivir resistance in transplant recipients with persistent coronavirus disease 2019;Hogan;Clin Infect Dis,2023

4. Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient;Baang;J Infect Dis,2021

5. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer;Avanzato;Cell,2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 Variants from Long-Term, Persistently Infected Immunocompromised Patients Have Altered Syncytia Formation, Temperature-Dependent Replication, and Serum Neutralizing Antibody Escape;Viruses;2024-09-09

2. Case reports of persistent SARS-CoV-2 infection outline within-host viral evolution in immunocompromised patients;Virology Journal;2024-09-03

3. Re: Persistent COVID-19 in immunocompromised patients—Israeli Society of Infectious Diseases consensus statement on diagnosis and management by Meijer et al.;Clinical Microbiology and Infection;2024-09

4. Management of severe COVID-19 in the ICU;COVID-19: An Update;2024-09-01

5. Introducing a framework for within-host dynamics and mutations modelling of H5N1 influenza infection in humans;2024-09-01